Recce Pharmaceuticals selected to participate in UK Government Innovation Agency’s AMR Mission 2024 Posted on April 11, 2024September 25, 2024 by recce_com Recce Pharmaceuticals selected to participate in UK Government Innovation Agency’s AMR Mission 2024
Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel Posted on April 9, 2024September 25, 2024 by recce_com Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel
Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel Posted on April 8, 2024September 25, 2024 by recce_com Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel
Recce Pharmaceuticals inks new patent for flagship drug in Israel Posted on April 3, 2024September 25, 2024 by recce_com Recce Pharmaceuticals inks new patent for flagship drug in Israel
Recce reaches testing milestone for UTI, Uroseptis antibiotic Posted on March 22, 2024September 25, 2024 by recce_com Recce reaches testing milestone for UTI, Uroseptis antibiotic
Recce Pharmaceuticals hits major milestone in R327 clinical trial for UTI/urosepsis Posted on March 18, 2024September 25, 2024 by recce_com Recce Pharmaceuticals hits major milestone in R327 clinical trial for UTI/urosepsis
Recce reaches testing milestone for UTI, Urosepsis antibiotic Posted on March 17, 2024September 25, 2024 by recce_com Recce reaches testing milestone for UTI, Urosepsis antibiotic
Recce Pharma (ASX:RCE) kicks-off dosing for next cohort of UTI trial Posted on March 13, 2024September 25, 2024 by recce_com Recce Pharma (ASX:RCE) kicks-off dosing for next cohort of UTI trial
Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital Posted on March 13, 2024September 25, 2024 by recce_com Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital
Biotech around the World: The Low-Down on the Land Down Under Posted on March 3, 2024September 25, 2024 by recce_com Biotech around the World: The Low-Down on the Land Down Under
